Literature DB >> 9125581

Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague.

R W Titball1, A M Howells, P C Oyston, E D Williamson.   

Abstract

The caf operon from Yersinia pestis encoding the structural subunit (caf1), the molecular chaperone (caf1M), the outer membrane anchor (caf1A), and the regulatory protein (caf1R) was cloned into Salmonella typhimurium SL3261 aroA. The recombinant Salmonella organisms were encapsulated when cultured at 37 degrees C but not when cultured at 28 degrees C. Oral inoculation of mice with the recombinant Salmonella induced predominantly an immunoglobulin G2a response to F1 antigen, and isolated T cells showed a recall response to soluble or Salmonella-associated F1 antigen. Mice immunized with S. typhimurium SL3261 aroA expressing F1 antigen intracellularly developed lower antibody responses to F1 antigen and showed a T-cell recall response only to Salmonella-associated F1 antigen. Mice immunized orally with two doses of the recombinant Salmonella which expressed F1 antigen on the surface were protected against 10(7) 50% lethal doses (LD50) of virulent Y. pestis given by the subcutaneous route of challenge, whereas mice immunized with the recombinant Salmonella expressing F1 antigen intracellularly were only partially protected against 10(5) LD50 of Y. pestis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125581      PMCID: PMC175242          DOI: 10.1128/iai.65.5.1926-1930.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Synthesis of the fraction I antigenic protein by Pasteurella pestis.

Authors:  E N FOX; K HIGUCHI
Journal:  J Bacteriol       Date:  1958-02       Impact factor: 3.490

2.  The basis of virulence in Pasteurella pestis: the development of resistance to phagocytosis in vitro.

Authors:  T W BURROWS; G A BACON
Journal:  Br J Exp Pathol       Date:  1956-06

3.  Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge.

Authors:  G P Andrews; D G Heath; G W Anderson; S L Welkos; A M Friedlander
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Method for quantitation of IgG subclass antibodies in mouse serum by enzyme-linked immunosorbent assay.

Authors:  R K Gupta; G R Siber
Journal:  J Immunol Methods       Date:  1995-04-12       Impact factor: 2.303

5.  Infectivity of pneumonic plague.

Authors:  P Cowling; P Moss
Journal:  BMJ       Date:  1994-11-19

6.  A new improved sub-unit vaccine for plague: the basis of protection.

Authors:  E D Williamson; S M Eley; K F Griffin; M Green; P Russell; S E Leary; P C Oyston; T Easterbrook; K M Reddin; A Robinson
Journal:  FEMS Immunol Med Microbiol       Date:  1995-12

7.  Expression of the envelope antigen F1 of Yersinia pestis is mediated by the product of caf1M gene having homology with the chaperone protein PapD of Escherichia coli.

Authors:  E E Galyov; A V Karlishev; T V Chernovskaya; D A Dolgikh; K I Volkovoy; V M Abramov; V P Zav'yalov
Journal:  FEBS Lett       Date:  1991-07-29       Impact factor: 4.124

8.  Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis.

Authors:  J Hess; I Gentschev; D Miko; M Welzel; C Ladel; W Goebel; S H Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

9.  Effectiveness of live or killed plague vaccines in man.

Authors:  K F Meyer
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

10.  A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model.

Authors:  P Russell; S M Eley; S E Hibbs; R J Manchee; A J Stagg; R W Titball
Journal:  Vaccine       Date:  1995-11       Impact factor: 3.641

View more
  23 in total

1.  Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis.

Authors:  Jim Hill; Catherine Copse; Sophie Leary; Anthony J Stagg; E Diane Williamson; Richard W Titball
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

2.  Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis.

Authors:  Debaditya Bhattacharya; Joan Mecsas; Linden T Hu
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

Review 3.  Developing live vaccines against plague.

Authors:  Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2011-09-14       Impact factor: 0.968

4.  Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague.

Authors:  Wei Sun; Shilpa Sanapala; Hannah Rahav; Roy Curtiss
Journal:  Vaccine       Date:  2015-10-26       Impact factor: 3.641

5.  LcrV plague vaccine with altered immunomodulatory properties.

Authors:  Katie A Overheim; R William Depaolo; Kristin L Debord; Elizabeth M Morrin; Debra M Anderson; Nathaniel M Green; Robert R Brubaker; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model.

Authors:  E D Williamson; P M Vesey; K J Gillhespy; S M Eley; M Green; R W Titball
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

7.  Effects of Psa and F1 on the adhesive and invasive interactions of Yersinia pestis with human respiratory tract epithelial cells.

Authors:  Fengzhi Liu; Huaiqing Chen; Estela M Galván; Melissa A Lasaro; Dieter M Schifferli
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

8.  Antibiotic-free plasmid stabilization by operator-repressor titration for vaccine delivery by using live Salmonella enterica Serovar typhimurium.

Authors:  Helen S Garmory; Matthew W Leckenby; Kate F Griffin; Stephen J Elvin; Rosa R Taylor; M Gill Hartley; Julian A J Hanak; E Diane Williamson; Rocky M Cranenburgh
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 9.  Promises and Challenges of the Type Three Secretion System Injectisome as an Antivirulence Target.

Authors:  Alyssa C Fasciano; Lamyaa Shaban; Joan Mecsas
Journal:  EcoSal Plus       Date:  2019-02

10.  Evaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plague.

Authors:  Wei Sun; Joseph Olinzock; Shifeng Wang; Shilpa Sanapala; Roy Curtiss
Journal:  Pathog Dis       Date:  2013-09-10       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.